Login / Signup

On-treatment changes of liver stiffness at week 26 could predict 2-year clinical outcomes in HBV-related compensated cirrhosis.

Shanshan WuYuanyuan KongHongxin PiaoWei JiangWen XieYongpeng ChenLungen LuAnlin MaShibin XieHuiguo DingJia ShangXuqing ZhangBo FengTao HanXiaoyuan XuLijuan HuoJilin ChengHai LiXiaoning WuJialing ZhouYameng SunXiaojuan OuHui ZhangHong YouJidong Jia
Published in: Liver international : official journal of the International Association for the Study of the Liver (2017)
Dynamic changes of LSM alone, or combined with baseline albumin, could predict LREs in patients with HBV-related compensated cirrhosis during antiviral therapy.
Keyphrases
  • hepatitis b virus
  • liver failure
  • stem cells
  • clinical trial
  • randomized controlled trial
  • bone marrow
  • combination therapy
  • study protocol
  • placebo controlled